COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-disciplinary expert committee)

• Главные авторы: Hardeep Singh Malhotra (Автор), Prashant Gupta (Автор), Divya Mehrotra (Автор), Himanshu Dandu (Автор), Neera Kohli (Автор), Veerendra Verma (Автор), Apjit Kaur (Автор), Neeraj Kumar (Автор), Vikas Prabhu (Автор), Manish Kumar Singh (Автор), Riddhi Jaiswal (Автор), Brijesh Mishra (Автор), Bal Krishna Ojha (Автор), Nitin Dutt Bhardwaj (Автор), Virendra Atam (Автор), Bipin Puri (Автор)
• Формат: ‌
• Опубликовано: Elsevier, 2021-10-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Even before the onslaught of COVID-19 pandemic could settle, the unprecedented rise in cases with COVID-19 associated mucormycosis pushed the medical health to the fringe. Hyperglycaemia and corticosteroids appear to be the most consistent associations leading to the commonest manifestation of mucor...